Drugs / pomegranate fruit extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02095145 | May 2014 → Jan 2018 | reproductive system cancer | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pomegranate fruit extract | “pomegranate fruit extract (PFE) 1000 mg, taken daily for 1 year” NCT02095145 ↗ |
| Known as | PFE | “pomegranate fruit extract (PFE) 1000 mg, taken daily for 1 year” NCT02095145 ↗ |
| Route | Oral | “Patients receive pomegranate-extract pill orally (PO) once daily (QD) for 52 weeks (+/- 1 week).” NCT02095145 ↗ |